Uplizna (inebilizumab-cdon), a medication for the treatment of neuromyelitis optica spectrum disorder (NMOSD), is now available in the U.S. through specialty distributor BioCareSD and specialty infusion pharmacy BioTek Remedys. The companies added the medication to their portfolio of specialty therapeutics to expand upon their product offering…
NMOSD
Recent Posts
- Should I complain about my NMOSD symptoms or not?
- NMOSD treatment approved in China blocks relapses, study finds
- Probing my spirituality in life with chronic illness and hardship
- New study identifies genetic variants tied to AQP4-positive NMOSD
- Uplizna cuts NMOSD relapse risk, even after using immunosuppressants